Sep 30, 2026

Featuring perspectives from Dr Shannon N Westin and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:

• Introduction (0:00)
• Ovarian Cancer (2:22)
• Endometrial Cancer (37:48)

CME information and select...

Sep 30, 2026

Featuring an interview with Dr Alexander E Drilon, including the following topics:

• Overview of targetable biomarkers in lung cancer (0:00)
• Biomarker testing for genomic alterations in lung cancer (5:24)
• Overview of ROS1 alterations in lung cancer (13:44)
• Efficacy data with ROS1 inhibitors for lung cancer (17:02)
• Safety...

Sep 29, 2026

Featuring an interview with Professor Nicoletta Colombo, including the following topics:

• Mechanistic effects and rationale underlying the use of relacorilant/nab paclitaxel (0:00)
• Rationale underlying the study design of the Phase II BELLA trial and avenues for future exploration (8:31)
• Definition of platinum...

Sep 29, 2026

Featuring a slide presentation and related discussion from Professor Nicoletta Colombo, including the following topics:

• Rationale for targeting the glucocorticoid receptor; relacorilant mechanism of action (0:00)
• Key efficacy and safety findings from a Phase II study of relacorilant/nab paclitaxel for...

Sep 28, 2026

Featuring perspectives from Dr Samuel J Klempner and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics:

• Introduction (0:00)
• First-Line Treatment of Metastatic Gastroesophageal Cancer (1:48)
• Management of HER2-Positive Gastroesophageal Cancer (25:11)
• Neoadjuvant Therapy for...